Lynda M. Vrooman

Postinduction Dexamethasone and Individualized Dosing of <i>Escherichia Coli</i> L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko et al. · Journal of Clinical Oncology · 2013 · 308 citations · Full text

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 234 citations

Medicine, Microbiology, Open-label Phase 3 +1

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

Inge M. van der Sluis, Lynda M. Vrooman, Rob Pieters et al. · Haematologica · 2016 · 225 citations · Full text

Urology, Allergy, Hypersensitivity +7

<i>Erwinia</i> asparaginase after allergy to <i>E. coli</i> asparaginase in children with acute lymphoblastic leukemia

Lynda M. Vrooman, Jeffrey G. Supko, Donna Neuberg et al. · Pediatric Blood & Cancer · 2009 · 158 citations · Full text

Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study

Benjamin Ole Wolthers, Thomas Leth Frandsen, André Baruchel et al. · The Lancet Oncology · 2017 · 125 citations

Pediatric Hematology, Asparaginase-associated Pancreatitis, Gastroenterology +3